Downregulation of MCL-1 and upregulation of PUMA using mTOR inhibitors enhance antitumor efficacy of BH3 mimetics in triple-negative breast cancer
Crossref DOI link: https://doi.org/10.1038/s41419-017-0169-2
Published Online: 2018-01-26
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Haolong
Liu, Lei http://orcid.org/0000-0001-9554-9634
Chang, Haocai
Zou, Zhengzhi
Xing, Da
Text and Data Mining valid from 2018-01-26
Version of Record valid from 2018-01-26
Article History
Received: 21 June 2017
Revised: 15 November 2017
Accepted: 20 November 2017
First Online: 26 January 2018
Conflict of interests
: The authors declare that they have no competing interests.